KMTS: the cash flow

MyFinsight

Cash Flow	2026-01-31	2025-10-31	2025-07-31
Net loss	-34,166	-32,785	-25,826
Depreciation and amortization	1,983	2,373	2,028
Loss on disposal of property and equipment	-167	-280	-280
Reserve for lost medical supplies	NaN	NaN	412
Reserve for lost equipment and supplies	699	901	NaN
Provision for uncollectible accounts receivable	365	537	613
Amortization of debt discounts and issuance costs	469	468	469
Share-based compensation expense	10,108	8,653	4,579
Non-cash lease expense	125	87	61
Change in fair value of warrant liabilities	-232	844	-2,909
Disposable medical equipment supplies	130	-136	-460
Prepaid expenses and other current assets	532	-813	-140
Accounts receivable	2,661	1,705	1,777
Accounts payable	1,725	524	-2,896
Accrued liabilities	3,672	1,380	-860
Operating lease liabilities	-228	-175	-138
Other long-term assets	-10	-10	-10
Net cash used in operating activities	-18,366	-18,343	-26,274
Purchases of property and equipment	9,797	7,265	8,166
Deposits for medical rental equipment	189	235	103
Refund of deposits for medical rental equipment	67	80	37
Investment in equity security	5,000	NaN	NaN
Net cash used in investing activities	-14,919	-7,420	-8,232
Proceeds from issuance of common stock	149,291	NaN	NaN
Payment of equity issuance costs	84	1,902	NaN
Payments of ipo offering costs	NaN	NaN	1,875
Deemed dividend for payments to third party on behalf of shareholder	25	NaN	NaN
Net cash provided by financing activities	149,182	-27	-1,875
Net increase in cash, cash equivalents and restricted cash	115,897	-25,790	-36,381
Beginning of period	62,171	237,929	NaN
End of period	115,897	175,758	NaN

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.